JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.12% |
| 2 | Financials | 12.1% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 8.72% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Editas Medicine
EDIT
$432M
| $3.24M | ﹤0.01% |
109,375
+92,705
| +556% | +$2.32M |
|
|
SYKE
2902
DELISTED
SYKES Enterprises Inc
SYKE
| $3.24M | ﹤0.01% |
87,534
-80,426
| -48% | -$2.72M |
|
|
CZZ
2903
DELISTED
Cosan Limited
CZZ
| $3.24M | ﹤0.01% |
141,666
-971,155
| -87% | -$17.2M |
|
2904
Artisan Partners
APAM
$2.97B
| $3.23M | ﹤0.01% |
100,097
+6,859
| +7% | +$198K |
|
2905
Orthofix Medical
OFIX
$415M
| $3.23M | ﹤0.01% |
69,865
-46,394
| -40% | -$2.18M |
|
2906
Jack in the Box
JACK
$358M
| $3.22M | ﹤0.01% |
41,290
-47,572
| -54% | -$3.94M |
|
2907
Innovative Industrial Properties
IIPR
$1.67B
| $3.21M | ﹤0.01% |
42,351
+612
| +1% | +$47.5K |
|
2908
CALL
Progressive
PGR
$121B
| $3.21M | ﹤0.01% |
+44,400
| New | +$3.2M |
|
2909
PUT
Carvana
CVNA
$81B
| $3.21M | ﹤0.01% |
+174,500
| New | +$2.92M |
|
2910
Oceaneering
OII
$5.08B
| $3.21M | ﹤0.01% |
215,446
-110,344
| -34% | -$1.53M |
|
2911
CALL
FirstEnergy
FE
$27.1B
| $3.2M | ﹤0.01% |
65,900
-5,600
| -8% | -$268K |
|
|
MAGN
2912
Magnera Corp
MAGN
$443M
| $3.2M | ﹤0.01% |
13,436
+10,308
| +330% | +$2.29M |
|
2913
Voyager Therapeutics
VYGR
$197M
| $3.19M | ﹤0.01% |
229,028
+29,569
| +15% | +$430K |
|
2914
PUT
Gen Digital
GEN
$17.7B
| $3.19M | ﹤0.01% |
125,000
| – | – |
|
2915
Greif
GEF
$5.03B
| $3.18M | ﹤0.01% |
72,037
-39,732
| -36% | -$1.64M |
|
|
HTZ
2916
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $3.18M | ﹤0.01% |
+201,900
| New | +$3.03M |
|
|
HMSY
2917
DELISTED
HMS Holdings Corp.
HMSY
| $3.17M | ﹤0.01% |
107,164
-145,696
| -58% | -$4.47M |
|
2918
CALL
Acadia Pharmaceuticals
ACAD
$5.07B
| $3.17M | ﹤0.01% |
+74,100
| New | +$3.22M |
|
2919
Standard Motor Products
SMP
$877M
| $3.17M | ﹤0.01% |
59,571
+9,717
| +19% | +$496K |
|
2920
California Water Service
CWT
$3.1B
| $3.17M | ﹤0.01% |
61,419
-18,838
| -23% | -$983K |
|
2921
CALL
Wolfspeed
WOLF
$1.64B
| $3.17M | ﹤0.01% |
68,600
-19,400
| -22% | -$905K |
|
2922
Bridgewater Bancshares
BWB
$614M
| $3.16M | ﹤0.01% |
229,550
+130,346
| +131% | +$1.65M |
|
2923
OraSure Technologies
OSUR
$277M
| $3.16M | ﹤0.01% |
393,819
-382,106
| -49% | -$3.09M |
|
2924
CALL
Akebia Therapeutics
AKBA
$248M
| $3.16M | ﹤0.01% |
500,000
-1,990,000
| -80% | -$9.46M |
|
2925
CALL
American Airlines Group
AAL
$9.97B
| $3.15M | ﹤0.01% |
110,000
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.